Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
Michimich.com/10311274

LONDON - Michimich -- Europe's leading digital pharma event is back. The 14th Annual Digital Pharma Advances Conference returns to the Grand Connaught Rooms, London, uniting 35+ senior executives from 13 of the world's top 20 pharmaceutical companies — including AstraZeneca, Pfizer, Novartis, Novo Nordisk, GSK, Teva, Bayer, and Roche — to explore practical AI applications, omnichannel marketing strategies, HCP engagement, and patient-centric approaches.

Pre-Conference AI Applications Workshop – 27th January

New for 2026, the half-day AI workshop offers hands-on, practical insights for pharma marketing teams. Attendees will learn how to:

• Enhance HCP engagement through AI
• Streamline omnichannel communications
• Apply real-world AI use cases while staying compliant

Speakers include leaders from Pfizer, Novartis, Roche, Sanofi, and Novo Nordisk, sharing strategies that can be implemented immediately.

More on Michimich.com

• Compressed Gas Technologies Highlights the Long-Term Value of On-Site Nitrogen Generation
• Xmas Delights Brings Show-Stopping Holiday Light Displays to Ann Arbor
• From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
• Future of Work Training Institute Launches the #1 Global AI & Career Transformation Community
• Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."

Conference Highlights – 28th January

High-Impact Digital Strategies
Kick off with insights on streamlining digital platforms, balancing online and face-to-face interactions, and leveraging data to measure ROI. Speaker: Sara Tea Di Niro, Teva.

AI in Action: Practical, Scalable Solutions
Explore responsible AI adoption, governance, and real-world applications that enhance engagement while keeping humans in the loop. Speaker: Margarida Batista, Grünenthal Group.

Optimised HCP Engagement Panel
Learn how to capture HCP attention with personalised, data-driven content. Speakers include Craig Adkins (Takeda), Kiren Kaur Dulai (Mundipharma), and Jag Singh (CSL Vifor).

Data and Omnichannel Insights
Deep-dive into using analytics to drive personalised content and optimise every touchpoint across channels. Speakers include Adam Thornton (Bristol Myers Squibb) and Ryan Twiname (LEO Pharma).

Patient-Centric Engagement and Compliance
Focus on patient needs, transparency, and ethical digital strategies, alongside practical guidance on regulatory compliance. Speakers include Simeón Baker (Genomics England) and Antonios Roussos (Astellas Pharma).

Additional panels and breakout discussions cover social media strategies, digital transformation, medical devices, cybersecurity, and personalised omnichannel approaches, providing attendees with a complete toolkit for 2026.

More on Michimich.com

• Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
• Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
• Trenton Launches Noel Nights: A New Holiday Tradition for Families
• Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
• Prudential Alarm Strengthens BOMA Support; Celebrates Team Member Finalist

"The Digital Pharma revolution continues to gather pace – and it's accelerating faster than ever. AI is transforming our ability to reach and engage both patients and HCPs, and in markets more crowded than ever, cutting through the noise with meaningful, timely, and targeted content is no longer optional, it's mission-critical. That's why I'm thrilled to be co-chairing the 14th Annual Digital Pharma Advances Conference in London, where trailblazing industry leaders will come together to share bold innovations, real-world strategies, and future-ready insights." said Jag Singh, CSL Vifor (morning co-chair)

Early bird tickets are available until Thursday, with savings of up to £379. Group discounts are also available.

Discover the strategies driving pharma innovation in 2026 — View the full agenda